RA Capital Management, L.P. 13D/13G Filings for Inozyme Pharma, Inc. (INZY)

RA Capital Management, L.P. 13D and 13G filings for Inozyme Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-11-15
4:35 pm
Sale		2021-11-1513GInozyme Pharma, Inc.
INZY		RA Capital Management, L.P.0
0.000%		-2,003,653decrease
(Position Closed)		Filing
2021-02-16
4:39 pm
Purchase		2020-12-3113GInozyme Pharma, Inc.
INZY		RA Capital Management, L.P.2,003,653
8.600%		2,003,653increase
(New Position)		Filing